The Added Value of Apparent Diffusion Coefficient to Cerebral Blood Volume in the Preoperative Grading of Diffuse Gliomas

References

1. 1.↵
   1. Warmuth C,
   2. Günther M,
   3. Zimmer C

   . Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. Radiology 2003;228: 523–32

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Hakyemez B,
   2. Erdogan C,
   3. Ercan I,
   4. et al

   . High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Clin Radiol 2005;60: 493–502

   CrossRefPubMed
3. 3.↵
   1. Hirai T,
   2. Murakami R,
   3. Nakamura H,
   4. et al

   . Prognostic value of perfusion MR imaging of high-grade astrocytomas: long-term follow-up study. AJNR Am J Neuroradiol 2008;29: 1505–10

   Abstract/FREE Full Text
4. 4.↵
   1. Bulakbasi N,
   2. Kocaoglu M,
   3. Farzaliyev A,
   4. et al

   . Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors. AJNR Am J Neuroradiol 2005;26: 2187–99

   Abstract/FREE Full Text
5. 5.↵
   1. Rollin N,
   2. Guyotat J,
   3. Streichenberger N,
   4. et al

   . Clinical relevance of diffusion and perfusion magnetic resonance in assessing intra-axial brain tumors. Neuroradiology 2006;48: 150–59

   CrossRefPubMed
6. 6.↵
   1. Sadeghi N,
   2. D'Haene N,
   3. Decaestecker C,
   4. et al

   . Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies. AJNR Am J Neuroradiol 2008;29: 476–82

   Abstract/FREE Full Text
7. 7.↵
   1. Cha S

   . Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 2006;27: 475–87

   FREE Full Text
8. 8.↵
   1. Gupta RK,
   2. Cloughesy TF,
   3. Sinha U,
   4. et al

   . Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol 2000;50: 215–26

   CrossRefPubMed
9. 9.↵
   1. Cha S,
   2. Knopp EA,
   3. Johnson G,
   4. et al

   . Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;233: 11–29
10. 10.↵
    1. Louis DN,
    2. Ohgaki H,
    3. Wiestler OD,
    4. et al.

    , eds. WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon, France: IARC Press; 2007
11. 11.↵
    1. Lacerda S,
    2. Law M

    . Magnetic resonance perfusion and permeability imaging in brain tumors. Neuroimaging Clin N Am 2009;19: 527–57

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Wetzel SG,
    2. Cha S,
    3. Johnson G,
    4. et al

    . Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 2002;224: 797–803

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Lee EJ,
    2. Lee SK,
    3. Agid R,
    4. et al

    . Preoperative grading of presumptive low-grade astrocytomas on MR imaging: diagnostic value of minimum apparent diffusion coefficient. AJNR Am J Neuroradiol 2008;29: 1872–77

    Abstract/FREE Full Text
14. 14.↵
    1. Knopp EA,
    2. Cha S,
    3. Johnson G,
    4. et al

    . Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211: 791–98

    CrossRefPubMedWeb of Science
15. 15.↵
    1. McKnight TR,
    2. Lamborn KR,
    3. Love TD,
    4. et al

    . Correlation of magnetic resonance spectroscopic and growth characteristics within grade II and III gliomas. J Neurosurg 2007;106: 660–66

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Law M,
    2. Yang S,
    3. Wang H,
    4. et al

    . Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24: 1989–98

    Abstract/FREE Full Text
17. 17.↵
    1. Kim HS,
    2. Kim SY

    . A prospective study on the added value of pulsed arterial spin labeling and apparent diffusion coefficients in the grading of gliomas. AJNR Am J Neuroradiol 2007;28: 1693–99

    Abstract/FREE Full Text
18. 18.↵
    1. Sugahara T,
    2. Korogi Y,
    3. Kochi M,
    4. et al

    . Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999;9: 53–60

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Aronen HJ,
    2. Gazit IE,
    3. Louis DN,
    4. et al

    . Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191: 41–51

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Law M,
    2. Yang S,
    3. Babb JS,
    4. et al

    . Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004;25: 746–55

    Abstract/FREE Full Text
21. 21.↵
    1. Boxerman JL,
    2. Schmainda KM,
    3. Weisskoff RM

    . Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006;27: 859–67

    Abstract/FREE Full Text
22. 22.↵
    1. Lev MH,
    2. Ozsunar Y,
    3. Henson JW,
    4. et al

    . Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol 2004;25: 214–21

    Abstract/FREE Full Text
23. 23.↵
    1. Lev MH,
    2. Rosen BR

    . Clinical applications of intracranial perfusion MR imaging. Neuroimaging Clin N Am 1999;9: 309–31

    PubMedWeb of Science
24. 24.↵
    1. Shin JH,
    2. Lee HK,
    3. Kwun BD,
    4. et al

    . Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol 2002;179: 783–89

    CrossRefPubMed
25. 25.↵
    1. Law M,
    2. Young RJ,
    3. Babb JS,
    4. et al

    . Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2008;247: 490–98

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Kwee TC,
    2. Galban CJ,
    3. Tsien C,
    4. et al

    . Comparison of apparent diffusion coefficients and distributed diffusion coefficients in high-grade gliomas. J Magn Reson Imaging 2010;31: 531–37

    CrossRefPubMed
27. 27.↵
    1. Kono K,
    2. Inoue Y,
    3. Nakayama K,
    4. et al

    . The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 2001;22: 1081–88

    Abstract/FREE Full Text
28. 28.↵
    1. Yamasaki F,
    2. Kurisu K,
    3. Satoh K,
    4. et al

    . Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology 2005;235: 985–91

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Kitis O,
    2. Altay H,
    3. Calli C,
    4. et al

    . Minimum apparent diffusion coefficients in the evaluation of brain tumors. Eur J Radiol 2005;55: 393–400

    CrossRefPubMed
30. 30.↵
    1. Calli C,
    2. Kitis O,
    3. Yunten N,
    4. et al

    . Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 2006;58: 393–403
31. 31.↵
    1. Yang D,
    2. Korogi Y,
    3. Sugahara T,
    4. et al

    . Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echo-planar perfusion and diffusion-weighted MRI. Neuroradiology 2002;44: 656–66

    CrossRefPubMed
32. 32.↵
    1. Stadnik TW,
    2. Chaskis C,
    3. Michotte A,
    4. et al

    . Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings. AJNR Am J Neuroradiol 2001;22: 969–76

    Abstract/FREE Full Text